HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 316 filers reported holding HAEMONETICS CORP in Q2 2024. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,294,016 | -18.9% | 76,079 | -16.4% | 0.84% | -11.5% |
| Q1 2024 | $7,763,607 | +29.8% | 90,962 | +30.1% | 0.95% | +13.2% |
| Q4 2023 | $5,980,569 | -25.0% | 69,940 | -21.4% | 0.84% | -42.3% |
| Q3 2023 | $7,969,216 | -18.7% | 88,962 | -22.7% | 1.46% | -14.0% |
| Q2 2023 | $9,796,294 | -15.9% | 115,061 | -18.2% | 1.70% | -33.0% |
| Q1 2023 | $11,646,235 | +11.9% | 140,740 | +6.3% | 2.53% | -8.6% |
| Q4 2022 | $10,411,530 | +21.5% | 132,378 | +14.3% | 2.77% | +13.7% |
| Q3 2022 | $8,572,000 | +425.9% | 115,797 | +363.2% | 2.44% | +306.2% |
| Q2 2022 | $1,630,000 | -16.1% | 25,000 | +42.9% | 0.60% | +33.0% |
| Q1 2021 | $1,943,000 | -28.0% | 17,500 | -42.0% | 0.45% | -40.7% |
| Q2 2020 | $2,700,000 | +78.8% | 30,147 | +99.0% | 0.76% | +8.7% |
| Q1 2020 | $1,510,000 | -78.2% | 15,147 | -74.9% | 0.70% | -65.0% |
| Q4 2019 | $6,923,000 | – | 60,250 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 1,014,941 | $33,077,000 | 3.62% |
| Camber Capital Management LP | 1,202,000 | $39,173,000 | 3.07% |
| AMERICAN CAPITAL MANAGEMENT INC | 718,380 | $23,412,000 | 2.76% |
| Van Berkom & Associates Inc. | 1,258,322 | $41,009,000 | 2.31% |
| SNYDER CAPITAL MANAGEMENT L P | 1,222,547 | $39,843,000 | 2.07% |
| KESTREL INVESTMENT MANAGEMENT CORP | 441,250 | $14,380,000 | 1.78% |
| STONE RUN CAPITAL, LLC | 33,740 | $1,100,000 | 0.80% |
| HERMES INVESTMENT MANAGEMENT LTD | 728,123 | $23,730,000 | 0.75% |
| ANCHOR CAPITAL ADVISORS LLC | 1,119,060 | $36,470,000 | 0.73% |
| Netols Asset Management, Inc. | 137,267 | $4,473,000 | 0.72% |